Advertisement

Topics

Australia Announces A “Fairer” Orphan Drugs Program, With New Eligibility And Validity Criteria

00:41 EDT 4 Jul 2017 | SCRIP

New orphan drug designations under Australia’s reformed program will lapse after six months, although there is a 12-month transitional period...

      

Related Stories

 

Original Article: Australia Announces A “Fairer” Orphan Drugs Program, With New Eligibility And Validity Criteria

NEXT ARTICLE

More From BioPortfolio on "Australia Announces A “Fairer” Orphan Drugs Program, With New Eligibility And Validity Criteria"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...